ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
16 Apr 2019

Notice of Annual General Meeting in Acarix AB

Press release April 16, 2019 Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "C...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
20 Feb 2019

Acarix Bokslutskommuniké 2018: Marknadsdynamiken är gynnsam för CADScor®System med förmåga att påverka utmaningarna på den globala sjukvårdsmarknaden

Malmö den 20 februari 2019Acarix Bokslutskommuniké 2018: Marknadsdynamiken är gynnsam för CADScor®System med ...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Regulatory, Report, Yearend
November 18, 2024
20 Feb 2019

Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market

Malmö, February 20, 2019Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges ...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
15 Feb 2019

Acarix anpassar processen för tysk ersättning – Lämnar in ny dokumentation i slutet av februari 2019

Press release Malmö, 15 februari, 2019Acarix anpassar processen för tysk ersättning- Lämnar in ny dokumentation i s...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
15 Feb 2019

Acarix adapts pathway for German reimbursement – Submission of new dossier by the end of February 2019

Press release Malmö, February 15, 2019Acarix adapts pathway for German reimbursement- Submission of new dossier by the end of Febr...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2018

Kundutvärdering av CADScor®System ger positivt resultat jämfört med befintliga metoder

Delårsrapport januari-september 2018Malmö den 14 november 2018Kundutvärdering av CADScor®System gerpositivt resulta...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2018

Customer evaluation of CADScor®System compares favorably against existing methods

Interim Report, January - September 2018Malmö, November 14, 2018Customer evaluation of CADScor®Systemcompares favorably agains...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Regulatory, Staff change, Swedish
November 18, 2024
13 Nov 2018

Acarix (FN STO: ACARIX) tillkännagav idag att styrelsen utsett Per Persson till verkställande direktör

Pressmeddelande Malmö, 13 november 2018Acarix (FN STO: ACARIX) tillkännagav idag att styrelsen utsett Per Persson till v...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Regulatory, Staff change
November 18, 2024
13 Nov 2018

Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer

Press release Malmö, November 13, 2018Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persso...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q2, Regulatory, Report, Swedish
November 18, 2024
21 Aug 2018

Acarix Delårsrapport, januari – juni 2018 : Acarix befäster sin ställning på nyckelmarknader genom att erbjuda läkare och patienter nya möjligheter

Delårsrapport, januari - juni 2018Malmö den 21 augusti 2018Acarix befäster sin ställning på nyckelmarknaderg...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q2, Regulatory, Report
November 18, 2024
21 Aug 2018

Acarix Interim Report, January – June 2018 : Acarix gains traction in key markets providing physicians and patients new opportunities

Interim Report, January - June 2018Malmö, August 21, 2018Acarix gains traction in key markets providingphysicians and patients new...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
23 May 2018

Kommuniké från årsstämman i Acarix

Kommuniké från årsstämman i AcarixÅrsstämman 2018 i Acarix AB ("Acarix" eller "Bolaget") hölls ...
Continue reading
  • «
  • ‹
  • 18
  • 19
  • 20
  • 21
  • 22
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.